Market Trends of United States Negative Pressure Wound Therapy Industry
The Single-use Device Segment is Expected to Show Significant Growth Over the Forecast Period
- Single-use NPWT devices are highly preferred in healthcare settings for infection prevention since they are highly convenient compared to reusable devices. These devices eliminate the need for sterilization and maintenance, saving time and resources. The major factors driving the segment growth include the high prevalence of sports injuries and chronic wounds, the presence of various wound care clinics in the country, and the active participation of prominent players in novel product launches.
- The growing sports injuries in the country are projected to fuel the segment growth over the forecast period. For instance, as per the September 2023 update from Johns Hopkins Sports Injury Statistics, in the United States, about 30.0 million children and teens participate in some form of organized sports, and more than 3.5 million suffer from various injuries every year. In addition, a large proportion of the people in the United States suffer from various chronic wounds every year, which is estimated to drive the demand for single-use NPWT devices during the forecast period. For instance, according to the article published by the American Academy of Home Care Medicine (AAHCM) in September 2022, around 6.5 million people, or 1 in 38 adults, are affected by chronic wounds in the United States every year. As per the same source, the estimated annual cost estimates for managing chronic wounds in the United States range from USD 28.1 billion to USD 96.8 billion. Therefore, the high proportion of people suffering from chronic wounds in the country is projected to drive the demand for single-use NPWT devices for effective wound care.
- Furthermore, the presence of numerous wound care clinics in the country is projected to drive segment growth during the forecast period by increasing the availability of single-use NPWT devices in the nation. For instance, according to the article published by the Dermatology Times in October 2022, currently, there are approximately 2,200 specialty wound care clinics in the United States, with nearly 2,000 associated with hospitals. The remaining ones are private practices focused exclusively on wound care. Thus, the presence of various wound care clinics in the country is projected to accelerate the segment growth during the forecast period.
- Moreover, the active participation of prominent players in the launch of advanced NPWT devices in the country is projected to drive segment growth during the forecast period. For instance, in May 2023, Smith+Nephew received an innovative technology contract from Vizient for PICO Single Use Negative Pressure Wound Therapy Systems in the United States.
- Therefore, factors such as the high prevalence of sports injuries and chronic wounds, the presence of various wound care clinics in the country, and the active participation of prominent players in novel product launches are projected to drive segment growth during the forecast period. Negative pressure wound therapy (NPWT) is a therapeutic technique that uses a suction dressing to remove excess exudate and promote healing in acute or chronic wounds and second and third-degree burns.
Understand The Key Trends Shaping This Market
Download PDF
The Diabetic Foot Ulcer Segment is Expected to Register a Significant Share of the Market Over the Forecast Period
- The factors driving the growth of the diabetic foot ulcer segment in the United States include the rising prevalence of diabetes and the increasing geriatric population in the country during the forecast period. The United States has seen a steady increase in diabetes cases, which is a significant risk factor for diabetic foot ulcers.
- As the diabetic population grows, the prevalence of foot ulcers also increases, which is driving the need for NPWT treatment. For instance, according to the article published by the Frontiers in Endocrinology Journal in July 2022, the lifetime incidence of foot ulcers in the United States is estimated to be 15%–25% among patients with diabetes.
- In addition, as per the data released by the IDF, in February 2022, approximately 32.2 million people had diabetes in the United States in 2021. The number is expected to increase to 34.7 million in 2030 and 36.2 million by the end of 2045. Similarly, as per the data released by the CDC in April 2023, approximately 37.3 million, or about 1 in 10 Americans, currently have diabetes. Thus, the rising prevalence of diabetes in the country is projected to drive the segment growth during the forecast period.
- Furthermore, the aging population is more susceptible to chronic conditions like diabetes. With a larger elderly demographic, there is a higher incidence of diabetic foot ulcers, contributing to the growth of this market segment. For instance, as per the data published by the Administration of Community Living (ACL) in April 2022, the American geriatric population is projected to reach 80.8 million by 2040 and 94.7 million by 2060.
- Therefore, the rising prevalence of diabetes and the increasing geriatric population in the country are projected to drive segment growth during the forecast period.
